Dorothee Frank

572 total citations
7 papers, 428 citations indexed

About

Dorothee Frank is a scholar working on Oncology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Dorothee Frank has authored 7 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Pharmacology and 2 papers in Infectious Diseases. Recurrent topics in Dorothee Frank's work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Dorothee Frank is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Dorothee Frank collaborates with scholars based in Germany, Switzerland and Netherlands. Dorothee Frank's co-authors include Uwe Fuhr, Ulrich Jaehde, Alexander Jetter, Oxana Doroshyenko, Dorota Tomalik‐Scharte, Tobias Klaassen, Julia Kirchheiner, Dieter Lütjohann, Edgar Schömig and Gerd Fätkenheuer and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Dorothee Frank

7 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothee Frank Germany 7 254 132 89 64 55 7 428
Susan M. Klein United States 6 220 0.9× 152 1.2× 169 1.9× 67 1.0× 31 0.6× 7 507
Aurel Constant Allabi Benin 9 263 1.0× 171 1.3× 99 1.1× 56 0.9× 25 0.5× 20 510
Edmund Jon Deoon Lee Singapore 14 210 0.8× 161 1.2× 66 0.7× 254 4.0× 97 1.8× 25 731
Muneaki Hidaka Japan 13 188 0.7× 105 0.8× 50 0.6× 153 2.4× 22 0.4× 34 594
Martine Lebot France 8 276 1.1× 202 1.5× 123 1.4× 94 1.5× 45 0.8× 10 660
Cornelia M. Smith United States 6 258 1.0× 126 1.0× 61 0.7× 110 1.7× 39 0.7× 7 574
R Temple United States 4 261 1.0× 192 1.5× 114 1.3× 113 1.8× 51 0.9× 5 554
Hiromitsu Imai Japan 13 164 0.6× 182 1.4× 107 1.2× 109 1.7× 30 0.5× 32 541
Aida Ortega‐Alonso Spain 14 446 1.8× 113 0.9× 45 0.5× 147 2.3× 29 0.5× 27 781
Kuang‐Chih Hsiao Australia 12 311 1.2× 94 0.7× 70 0.8× 149 2.3× 11 0.2× 28 755

Countries citing papers authored by Dorothee Frank

Since Specialization
Citations

This map shows the geographic impact of Dorothee Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothee Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothee Frank more than expected).

Fields of papers citing papers by Dorothee Frank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothee Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothee Frank. The network helps show where Dorothee Frank may publish in the future.

Co-authorship network of co-authors of Dorothee Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothee Frank. A scholar is included among the top collaborators of Dorothee Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothee Frank. Dorothee Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Tomalik‐Scharte, Dorota, Uwe Fuhr, Martin Hellmich, et al.. (2011). Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide. Drug Metabolism and Disposition. 39(5). 927–932. 31 indexed citations
2.
Abduljalil, Khaled, Dorothee Frank, Andrea Gaedigk, et al.. (2010). Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan. Clinical Pharmacology & Therapeutics. 88(5). 643–651. 51 indexed citations
3.
Jetter, Alexander, Gerd Fätkenheuer, Dorothee Frank, et al.. (2010). Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients?. Antiviral Therapy. 15(7). 975–983. 31 indexed citations
4.
Tomalik‐Scharte, Dorota, Dieter Lütjohann, Oxana Doroshyenko, et al.. (2009). Plasma 4β-Hydroxycholesterol: An Endogenous CYP3A Metric?. Clinical Pharmacology & Therapeutics. 86(2). 147–153. 59 indexed citations
5.
Doroshyenko, Oxana, Uwe Fuhr, Dorothee Frank, et al.. (2009). In vivoRole of CytochromeP450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans. Cancer Epidemiology Biomarkers & Prevention. 18(2). 433–443. 63 indexed citations
6.
Wyen, Christoph, Uwe Fuhr, Dorothee Frank, et al.. (2008). Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients. Clinical Pharmacology & Therapeutics. 84(1). 75–82. 67 indexed citations
7.
Frank, Dorothee, Ulrich Jaehde, & Uwe Fuhr. (2007). Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. European Journal of Clinical Pharmacology. 63(4). 321–333. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026